FDA Inspection
Reliance Life Sciences Private LimitedReliance Life Sciences Private Limited – FDA Inspection, Apr 15, 2022
Record Details
This FDA Inspection record concerns Reliance Life Sciences Private Limited, with an inspection on April 15, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 15, 2022
- Product Type
- Drugs
View Company Profile
ID · 25bd4384-4ea7-4998-8065-2fb38edb15d1
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1170339
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Reliance Life Sciences Private Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2026 | Not classified | Office of Inspections and Investigations | |
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| October 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Reliance Life Sciences Private Limited
- FDA Inspection 1311632 - 2026-02-27
- FDA Inspection 1113122 - 2019-11-22
- FDA Inspection 1081821 - 2019-02-22
- FDA Inspection 1070144 - 2018-10-16
- FDA Inspection 1047623 - 2018-01-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.